SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A. Albornoz, Trent M. Woodruff, Daniella Bradshaw et al.|Molecular Psychiatry|2022Cited by 178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, Julian D. J. Sng et al.|Nature Communications|2021Cited by 177
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2Alberto A. Amarilla, Daniel Watterson, Naphak Modhiran et al.|Frontiers in Microbiology|2021Cited by 69
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Clinical & Translational Immunology|2021Cited by 62
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccineChristopher L. D. McMillan, David A. Muller, Jovin J. Y. Choo et al.|Science Advances|2021Cited by 47